Blue Ribbon Panel Report Cover Letter

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Dear Vice President Biden:

Thanks to your leadership of the Cancer Moonshot, the Blue Ribbon Panel (BRP) was assembled with the goal of identifying a focused number of game-changing initiatives that will accelerate progress in cancer. The BRP, a working group of the National Cancer Institute’s (NCI’s) National Cancer Advisory Board, comprises 28 outstanding experts and leaders from a diverse array of research disciplines, the advocacy and philanthropy community, and the private sector. I am indebted to them and the 150 members of the seven working groups who put aside business as usual to contribute their years of expertise to collaborate on this unprecedented opportunity. The panel and working groups also took into consideration more than 1,600 scientific ideas sent in from the research community and public, as well as substantive recommendations communicated at professional meetings and forums around the country. 

I am confident that the BRP report provides a blueprint for key initiatives whose timely implementation can make major contributions towards achieving a decade’s worth of progress against cancer in 5 years. It lays out 10 bold but feasible recommendations, representing the merger of science, technology, social science, and big data, to solve cancer’s greatest challenges and promote cancer health equity. These recommendations are built upon the fundamental knowledge gained from decades of investment in biomedical research by some of the world’s greatest minds and set the stage for rapid progress across the cancer continuum, including prevention, screening, diagnosis, treatment, and survivorship.

I would like to personally thank you for your commitment to this effort, and your boundless enthusiasm for achieving greater and faster progress. Your leadership has galvanized researchers, advocates, patients, and private- and public-sector leaders as never before, and they are committed to working collaboratively on a blueprint that will help transform the future direction of cancer research and care. NCI is energized and optimistic.  We stand ready to build on this momentum and move forward so that we may improve the quality of life for those who are at the heart of and the reason for all that we do.

Douglas R. Lowy, M.D.
Acting Director, National Cancer Institute

  • Posted: October 17, 2016